Gf Fund Management Co. Ltd. Terns Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,174 shares of TERN stock, worth $8,478. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,174
Previous 1,783
21.93%
Holding current value
$8,478
Previous $9.88 Million
39.26%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TERN
# of Institutions
143Shares Held
84.5MCall Options Held
256KPut Options Held
133K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$31.9 Million1.87% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$29.5 Million0.65% of portfolio
-
Morgan Stanley New York, NY7.11MShares$27.7 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$26.9 Million5.17% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$21.7 Million0.54% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $147M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...